Femasys Inc has a consensus price target of $9.4 based on the ratings of 21 analysis. The 3 most-recent analyst ratings were released by HC Wainwright & Co., HC Wainwright & Co., and Chardan Capital on June 20, 2024, May 9, 2024, and April 1, 2024, respectively. With an average price target of $12.67 between HC Wainwright & Co., HC Wainwright & Co., and Chardan Capital, there's an implied 1011.11% upside for Femasys Inc from these most-recent analyst ratings.
1calculated from analyst ratings
Buy Now | Get Alert | |||||||
---|---|---|---|---|---|---|---|---|
06/20/2024 | Buy Now | 1040.35% | HC Wainwright & Co. | Emily Bodnar | $13 → $13 | Reiterates | Buy → Buy | Get Alert |
05/09/2024 | Buy Now | 1040.35% | HC Wainwright & Co. | Emily Bodnar | → $13 | Reiterates | Buy → Buy | Get Alert |
04/01/2024 | Buy Now | 952.63% | Chardan Capital | Keay Nakae | $12 → $12 | Maintains | Buy | Get Alert |
04/01/2024 | Buy Now | 952.63% | HC Wainwright & Co. | Emily Bodnar | $10 → $12 | Maintains | Buy | Get Alert |
03/21/2024 | Buy Now | 952.63% | Chardan Capital | Keay Nakae | → $12 | Reiterates | Buy → Buy | Get Alert |
03/21/2024 | Buy Now | 777.19% | HC Wainwright & Co. | Emily Bodnar | → $10 | Reiterates | Buy → Buy | Get Alert |
03/20/2024 | Buy Now | 777.19% | JonesTrading | Catherine Novack | $7 → $10 | Maintains | Buy | Get Alert |
11/14/2023 | Buy Now | 777.19% | HC Wainwright & Co. | Emily Bodnar | $13 → $10 | Maintains | Buy | Get Alert |
09/29/2023 | Buy Now | 1040.35% | HC Wainwright & Co. | Emily Bodnar | $5 → $13 | Maintains | Buy | Get Alert |
09/26/2023 | Buy Now | 514.04% | JonesTrading | Lina Kaminski | $5 → $7 | Maintains | Buy | Get Alert |
08/11/2023 | Buy Now | 777.19% | Chardan Capital | Keay Nakae | → $10 | Reiterates | Buy → Buy | Get Alert |
08/10/2023 | Buy Now | 338.6% | HC Wainwright & Co. | Emily Bodnar | → $5 | Reiterates | Buy → Buy | Get Alert |
07/03/2023 | Buy Now | 777.19% | Chardan Capital | Keay Nakae | → $10 | Reiterates | Buy → Buy | Get Alert |
03/31/2023 | Buy Now | 777.19% | Chardan Capital | Keay Nakae | $12 → $10 | Maintains | Buy | Get Alert |
11/11/2022 | Buy Now | 952.63% | Chardan Capital | Keay Nakae | $15 → $12 | Maintains | Buy | Get Alert |
10/21/2022 | Buy Now | 338.6% | HC Wainwright & Co. | Emily Bodnar | $8 → $5 | Maintains | Buy | Get Alert |
06/17/2022 | Buy Now | 338.6% | Maxim Group | Jason McCarthy | → $5 | Initiates | → Buy | Get Alert |
03/25/2022 | Buy Now | 1478.95% | Chardan Capital | Keay Nakae | $25 → $18 | Maintains | Buy | Get Alert |
03/24/2022 | Buy Now | 601.75% | HC Wainwright & Co. | Emily Bodnar | → $8 | Initiates | → Buy | Get Alert |
07/13/2021 | Buy Now | 1478.95% | JonesTrading | Lina Kaminski | — | Initiates | → Buy | Get Alert |
07/13/2021 | Buy Now | 2092.98% | Chardan Capital | Keay Nakae | — | Initiates | → Buy | Get Alert |
The latest price target for Femasys (NASDAQ:FEMY) was reported by HC Wainwright & Co. on June 20, 2024. The analyst firm set a price target for $13.00 expecting FEMY to rise to within 12 months (a possible 1040.35% upside). 12 analyst firms have reported ratings in the last year.
The latest analyst rating for Femasys (NASDAQ:FEMY) was provided by HC Wainwright & Co., and Femasys reiterated their buy rating.
There is no last upgrade for Femasys
There is no last downgrade for Femasys.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Femasys, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Femasys was filed on June 20, 2024 so you should expect the next rating to be made available sometime around June 20, 2025.
While ratings are subjective and will change, the latest Femasys (FEMY) rating was a reiterated with a price target of $13.00 to $13.00. The current price Femasys (FEMY) is trading at is $1.14, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.